Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002092127-25-000004
Filing Date
2025-10-22
Accepted
2025-10-22 20:47:47
Documents
1
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5830
  Complete submission text file 0002092127-25-000004.txt   7603
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE SUMMIT SQUARE 1717 LANGHORNE NEWTOWN ROAD, SUITE 300 LANGHORNE PA 19047
Business Address
Wasfi Yasmine (Reporting) CIK: 0002092127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 251411202